Our story on the FDA’s advisory of an updated clinical bulletin from Hospira regarding its Class I recall of the Symbiq one-channel infuser and Symbiq two-channel infuser was the second most read story on 24x7mag.com last week.

Hospira recalled the system in April due to numerous customer complaints of the Symbiq infusion pump’s failure to detect air-in-line conditions during operation. Nearly 30,000 affected devices have been distributed worldwide.

According to the FDA, Hospira’s letter, mailed in June, states that users do not have to remove or stop using the infusion pump, but should follow recommended mitigation actions.

Read the full Weekly Jolt report or view the FDA’s full recall notice online.
 

SPONSORS